Corpus Intelligence IC Memo — SSH - TRI-CITIES INC. 2026-04-26 12:30 UTC
IC Memo — SSH - TRI-CITIES INC.
Investment Committee Memorandum | TN | 35 beds | Grade D | EBITDA uplift $1.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SSH - TRI-CITIES INC.

CCN 442016 | SULLIVAN, TN | 35 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

SSH - TRI-CITIES INC. is a 35-bed community hospital in SULLIVAN, TN with $20.0M in net patient revenue and a 9.0% operating margin. The hospital serves a payer mix of 24.1% Medicare, 0.0% Medicaid, and 75.9% commercial.

Thesis: Turnaround. Our ML models identify $1.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 9.0% to 16.4% (+736bps).

Net Revenue HCRIS$20.0M
Current EBITDA COMPUTED$1.8M
Operating Margin COMPUTED9.0%
Occupancy HCRIS87.4%
Revenue / Bed COMPUTED$572K
Net-to-Gross HCRIS13.2%
Distress Probability MLnan%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
63
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 9.0% places it above the state median. Among 63 size-comparable peers (18-70 beds), the median margin is -0.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (18-70), prioritizing same-state peers. 63 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SSH - TRI-CITIES INC. (Target)TN35$20.0M9.0%
BAPTIST MEM HOSPITAL TIPTON COTN48$179.0M-5.8%
INDIAN PATH COMMUNITY HOSPITALTN35$142.8M12.0%
LECONTE MEDICAL CENTERTN60$126.3M6.4%
HENRY COUNTY MEDICAL CENTERTN43$81.7M-13.0%
THE CENTER FOR SPINAL SURGERYTN23$78.7M39.3%
JEFFERSON MEMORIAL HOSPITALTN58$61.3M12.7%
SWEETWATER HOSPITAL ASSOCIATIOTN55$56.6M-10.8%
ASCENSION ST THOMAS RIVER PARKTN56$53.9M-11.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$421K+210bp18mo
Cost to Collect4.5%2.5%$401K+200bp12mo
Denial Rate Reduction12.0%6.5%$397K+198bp12mo
A/R Days Reduction5200.0%3800.0%$244K+122bp9mo
Clean Claim Rate88.0%96.0%$13K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$421K
Cost to Collect
$401K
Denial Rate Reduction
$397K
A/R Days Reduction
$244K
Clean Claim Rate
$13K
Total EBITDA Uplift$1.5M
Current EBITDA$1.8M
+ RCM Uplift+$1.5M
Pro Forma EBITDA$3.3M
Current Margin9.0%
Pro Forma Margin16.4%
WC Released (1x)$768K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$2.8M$26.7M9.59x57.2%
Base (11x exit)10.0x11.0x$2.8M$30.2M10.88x61.2%
Bull Case9.0x11.0x$2.5M$36.0M14.39x70.5%
Bull (12x exit)9.0x12.0x$2.5M$40.0M16.00x74.1%
Bear Case11.0x10.0x$3.1M$18.4M6.01x43.2%
Bear (11x exit)11.0x11.0x$3.1M$21.2M6.94x47.3%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 63 hospitals with 18-70 beds
  • Same-state prioritization (n=64)
  • Comp margins: P25=-14.9% / P50=-0.8% / P75=7.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.